Monday, February 2, 2026

TerrAscend: Analyst Consensus Estimates For Q3 2021

TerrAscend Corp (CSE: TER) announced that they will be reporting their third quarter financials before the markets open on November 16th.

Analysts have a consensus C$17.96 12-month price target on the company, via a total of 8 analysts, with 3 analysts having strong buy ratings, and the other 5 having buy ratings on the company. The street high comes from Stifel-GMP with an C$23 price target, and the lowest target comes from Needham & Company with a C$13.70 price target.

8 analysts have revenue estimates for the third quarter. The mean between all 8 is US$57.82 million; this number has been revised down from US$80.98 million at the start of May. The street high is US$62 million while the lowest sits at US$54.30 million.

7 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 57.84%, with this number being lower than at the start of May. Street high is 60.70% estimate and the lowest sits at 52%.

Onto EBITDA estimates, there are currently 8 analysts who have third quarter EBITDA estimates. The mean is currently US$19.98 million, with this number has been revised downwards from US$34.01 million at the start of May. Street high sits at US$23.40 million EBITDA and the lowest being a US$15.90 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

Total Metals Launches 5,500 Metre Drill Program At ElectroLode Property

Mercado Minerals Launches Two Phase Geophysical Program At Copalito Project

Related News

BMO Raises Jazz Pharmaceuticals Price Target To US$205

It was announced last week wednesday that Jazz Pharmaceuticals (NASDAQ: JAZZ) would be acquiring GW...

Monday, February 8, 2021, 10:40:00 AM

PI Financial: US Cannabis Has “Good Growth Prospects”

On Tuesday, PI Financial released their fourth quarter 2021 earnings review on their cannabis sector....

Thursday, April 21, 2022, 02:21:00 PM

GAGE Cannabis: PI Financial Reiterates Their Street High Target, Lowers 2021 Estimates

On August 24, Gage Growth Corp. (CSE: GAGE) announced their second quarter financial results. The...

Saturday, August 28, 2021, 11:13:00 AM

BMO Lowers Maple Leaf Foods’ Earnings Estimates On Expected Headwinds

Maple Leaf Foods (TSX: MFI) is expected to report its second-quarter financial results on August...

Saturday, July 9, 2022, 03:17:00 PM

Coinbase Sees Canaccord More Than Halve Price Target To $120

On May 10th, Coinbase Global (NASDAQ: COIN) reported its first-quarter financial results, posting $1.165 billion...

Saturday, May 14, 2022, 03:16:00 PM